RSS   Newsletter   Contact   Advertise with us

Superbugs to kill more than cancer by 2050

Share on Twitter Share on LinkedIn
Staff writer ▼ | January 2, 2015
Infections that are resistant to anti-bacterial drugs will cause 10 million new deaths every year by 2050, warns a report from the Review on Antimicrobial Resistance (AMR).
Warning   The Review on Antimicrobial Resistance
The study, commissioned by the U.K. government, estimates that the deaths would claim 2-3.5 percent of GDP worldwide.

"The research was commissioned to understand the economic cost of AMR, interpreted strictly as its impact on global GDP. Other issues, such as social and healthcare costs, were not considered," write the report's authors. "If AMR continues to grow as a major problem in the world it will have enormous consequences for how we deliver healthcare."

The superbugs having the biggest impact would be E.coli, malaria and tuberculosis.

The authors have been commissioned to produce a follow-up report by 2016, compiling solutions to the impending threat. Probably solutions include changing the use of anti-bacterial drugs, increasing development of new drugs and new regulations for drug use in humans and animals.